Lloyd Mitchell Segal
CIK: 0001477123
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)1 (33.3%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (33.3%)
Compensation grants
Other (G, F, J, C, D, …)1 (33.3%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
About Segal Lloyd Mitchell
Segal Lloyd Mitchell (SEC CIK 0001477123) files insider reports with the SEC as Director of Aktis Oncology, Inc. (AKTS) and PRESIDENT AND CEO of Repare Therapeutics Inc. (RPTX).
Signal8 holds 4 ownership filings by Segal Lloyd Mitchell (1 Form 3, 3 Form 4), filed between Mar 6, 2025 and Jan 12, 2026. Those filings report 3 transactions, from Mar 4, 2025 to Jan 12, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Segal Lloyd Mitchell's filings is in BOSTON, MA.
Recent filings by Segal Lloyd Mitchell
Other insiders filing for Aktis Oncology, Inc. (AKTS)
- Czibere Akos, Chief Medical Officer
- Herrmann Ken, Director
- Ron-Bigger Shulamit, Chief Operating Officer
- Gormley Glenn, Director
- ELI LILLY & Co, 10% Owner
- Foley Todd, Director